Empirical antimicrobial therapy for odontogenic infections.
Limeres
Jacobo
J
Tomás
I
I
Alvarez
M
M
Diz
Pedro
P
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001372:Aza Compounds / Q000494:pharmacology / Q000627:therapeutic use; D001421:Bacteria, Anaerobic / Q000187:drug effects / Q000472:pathogenicity; D024841:Fluoroquinolones; D005491:Focal Infection, Dental / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D010482:Periapical Abscess / Q000188:drug therapy* / Q000382:microbiology; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D013290:Streptococcal Infections / Q000188:drug therapy*; D013291:Streptococcus / Q000187:drug effects / Q000472:pathogenicity; D018440:beta-Lactam Resistance
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin